IDEX Corporation

Valuation Analysis

About the Company

IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally. It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces, and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, and custom mechanical and shaft seals. This segment also offers engineered hygienic mixers and valves, biocompatible medical devices and implantable products, air compressors and blowers, optical

IDEX Corporation Stock at a Glance

IDEX Corporation (IEX) is currently trading at $218.49 with a market capitalization of $16.2B. The trailing P/E ratio stands at 32.37x, with a forward P/E of 23.67x. The 52-week range spans from $157.25 to $223.94; the current price is 2.4% below the yearly high. Year-over-year revenue growth stands at +8.9%. The net profit margin stands at 14.38%.

💰 Dividend

IDEX Corporation pays an annual dividend of $2.92 per share, representing a yield of 1.34%. The payout ratio stands at 42.01%.

📊 Analyst Rating

14 analysts rate IDEX Corporation (IEX) on consensus: Buy. The average price target is $238.29, implying +9.06% from the current price. Analyst price targets range from $210.00 to $260.00.

IDEX Corporation: The Investment Case in Detail

IDEX Corporation (IEX) operates in the Industrials — specifically Specialty Industrial Machinery — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Earnings growth of 27.8% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. The combination of a 44.44% gross margin and 19.89% operating margin shows the business converts revenue into profit efficiently — a hallmark of competitive moat.

The Bear Case

Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

What to Watch Next

• The forward P/E of 23.67x is meaningfully below the trailing 32.37x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 91.8% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy IDEX Corporation?

Compare top-rated brokers — low fees, trusted providers, fully regulated.